Ryouichi Tsunedomi

Yamaguchi, 7538515, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 70 publications

Switching of the c-Myc protein degradation pathway depending on the PP2A-B55α complex levels.

Switching of the c-Myc protein degradation pathway depending on the PP2A-B55α complex levels.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: March 12, 2026

Refining Outcomes in Technically Resectable Colorectal Liver Metastases: A Simplified Risk Model and the Role of Preoperative Chemotherapy.

Refining Outcomes in Technically Resectable Colorectal Liver Metastases: A Simplified Risk Model and the Role of Preoperative Chemotherapy.

Journal: Cancers

Published: December 10, 2025

Immature Peritumoral Tertiary Lymphoid Structures Indicate Poor Prognosis in Pancreatic Ductal Adenocarcinoma After NAC.

Immature Peritumoral Tertiary Lymphoid Structures Indicate Poor Prognosis in Pancreatic Ductal Adenocarcinoma After NAC.

Journal: Anticancer research

Published: December 01, 2025

Novel organoid-based exploration reveals the role of LMTK3/FADS2 signaling in metastatic breast cancer progression in felines and humans.

Novel organoid-based exploration reveals the role of LMTK3/FADS2 signaling in metastatic breast cancer progression in felines and humans.

Journal: Scientific reports

Published: August 18, 2025

Reconsidering upfront surgery for resectable pancreatic ductal adenocarcinoma: The role of risk stratification and neoadjuvant chemotherapy.

Reconsidering upfront surgery for resectable pancreatic ductal adenocarcinoma: The role of risk stratification and neoadjuvant chemotherapy.

Journal: Surgical oncology

Published: August 09, 2025

Immunogenicity of Neoantigens in Colorectal Cancer: Potential Influence of Tumor Mutation Burden, Stages, and Metastasis.

Immunogenicity of Neoantigens in Colorectal Cancer: Potential Influence of Tumor Mutation Burden, Stages, and Metastasis.

Journal: Anticancer research

Published: April 01, 2025

A Case of Inflammatory Myofibroblastic Tumor in the Abdominal Wall with Anaplastic Lymphoma Kinase and Whole Exome Sequencing Analysis.

A Case of Inflammatory Myofibroblastic Tumor in the Abdominal Wall with Anaplastic Lymphoma Kinase and Whole Exome Sequencing Analysis.

Journal: Surgical case reports

Published: March 25, 2025

The C11orf24 Gene as a Useful Biomarker for Predicting Severe Neutropenia in Modified FOLFIRINOX for Pancreatic Cancer.

The C11orf24 Gene as a Useful Biomarker for Predicting Severe Neutropenia in Modified FOLFIRINOX for Pancreatic Cancer.

Journal: Cancer science

Published: January 27, 2025

Novel immune drug combination induces tumour microenvironment remodelling and reduces the dosage of anti-PD-1 antibody.

Novel immune drug combination induces tumour microenvironment remodelling and reduces the dosage of anti-PD-1 antibody.

Journal: Scientific reports

Published: August 21, 2024

Safety and Feasibility of Neoadjuvant-Modified FOLFIRINOX in Elderly Patients with Pancreatic Cancer.

Safety and Feasibility of Neoadjuvant-Modified FOLFIRINOX in Elderly Patients with Pancreatic Cancer.

Journal: Cancers

Published: May 31, 2024

Exosomal miR-141-3p Induces Gemcitabine Resistance in Biliary Tract Cancer Cells.

Exosomal miR-141-3p Induces Gemcitabine Resistance in Biliary Tract Cancer Cells.

Journal: Anticancer research

Published: April 15, 2024

Protein phosphatase 6 promotes stemness of colorectal cancer cells.

Protein phosphatase 6 promotes stemness of colorectal cancer cells.

Journal: Cancer science

Published: March 07, 2024

Showing 1-12 of 70

Last Updated: 09/26/2026